((2R,4R)-4-Fluoro-1-methylpyrrolidin-2-yl)methanol, 98%, 1g

tert-Butyl 2-pyrazin-2-yl-5-(pyrrolidin-1-ylcarbonyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate, 50mg

1,1,2,2-tétrachloroéthane D2, 99,5 at%D, 7,5 ml, emballage en verreamp.

1-(2-Chloro-4-nitrophenyl)-4-methylpiperidine, 25g

Methyl 1H-indole-2-carboxylate, 95.0%, 500g

5-[1-(4-chloro-2-methylphenoxy)ethyl]-4-ethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

Ethyl-(4-methoxy-benzyl)-amine, 97.0%, 1g

3-Benzoyl-2-thiophenecarboxylic acid, 96.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenol>98.0%(GC)1g

2-AMINO-5-METHYL-4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE-3-CARBOXAMIDE, 90.0%, 5g

tert-butyl 3-bromo-2-oxopyrrolidine-1-carboxylate, 95.0%, 100mg

(2-Chlorophenyl)(phenyl)methanone, 98.0%, 25g

Methyl 5-bromo-4-hydroxynicotinate, 95.0%, 1g